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ABSTRACT: Reaction of 4-aryl-1,1,1-triﬂuorobut-3-en-2-ols
[CF3-allyl alcohols, ArCHCHCH(OH)CF3] with arenes
under activation with anhydrous FeCl3 or FSO3H was studied.
We found that the transformation led to triﬂuoromethylated
alkenes [Ar(Ar′)CHCHCHCF3] or 1-triﬂuoromethylated
indanes (CF3-indanes). The formation of these two types of reaction products strongly depends on the nucleophilicity of the
starting arene and the electrophilicity of cationic intermediates generated from CF3-allyl alcohols under reaction conditions.
Benzene, anisole, veratrole, and ortho-xylene lead exclusively to CF3-alkenes with an E-conﬁguration. More π-donating
polymethylated arenes (pseudocumene, mesitylene) aﬀord only CF3-indanes with a predominantly cis-orientation of substituents
at positions 1 and 3 of the indane ring. Meta- and para-xylenes show an intermediate behavior; they may form both CF3-alkenes
and/or CF3-indanes. The mechanisms of the investigated transformations are discussed.
■ INTRODUCTION
Fluorinated organic compounds have signiﬁcant theoretical and
practical value in chemistry, biology, medicine, and material
science.1,2 Incorporation of a ﬂuorinated moiety into a molecule
often changes such important parameters as lipophilicity,
metabolic activity, and bioavailability. Triﬂuoromethylated
alkenes (styrenes) are compounds of high practical interest.
Some derivatives with such fragments have been widely used
for organic light-emitting diodes (OLEDs) and other material
chemistry applications.3 Some triﬂuoromethylated alkenes
attract signiﬁcant attention due to important biological activity
and application in medicine. Incorporation of a CF3 group
permits one to design more potent drugs. For example,
Tamoxifen (Nolvadex) is the well-known triarylethylene-type
antiestrogenic drug,4 which is used in the therapy of breast
cancer and for the treatment of menstrual disorders.5
Panomifene is a triﬂuoromethylated analogue of Tamoxifen
(Figure 1). This drug demonstrated higher anticancer activity;
however, quite important is the conﬁguration of the double
bond because only one diastereomer can be used.
The electron-withdrawing character of ﬂuorinated groups is
another advantage, which allows one to control the selectivity
of transformations of ﬂuorinated compounds. CF3-substituted
carbocations are very promising, but still very rare, ﬂuorinated
species exhibiting high electrophilicity and selectivity.6 The
present work is a continuation of our investigations on the
electrophilic activation of alkenes7 and alkynes.8 In a
preliminary short communication,9 we showed that 4-phenyl-
1,1,1-triﬂuorobut-3-en-2-ol 1a alkylated selected aromatics to
aﬀord E-4,4-diaryl-1,1,1-triﬂuorobut-2-enes 2 under action of
various Brønsted or Lewis acids. The best results (highest yields
of compounds 2) were obtained using 1 equiv of anhydrous
iron trichloride FeCl3 (Scheme 1).
Interaction of CF3-alcohols 1 with Brønsted or Lewis acids
proceeds through intermediate formation of various electro-
philic species. Thus, coordination of oxygen with a Lewis acid
or protonation with a Brønsted acid leads to species B or C,
correspondingly (Scheme 2). Finally, dehydroxylation of
Received: June 25, 2015
Published: September 3, 2015
Figure 1. Tamoxifen and panomifene.
Scheme 1. Reactions of CF3-alcohol 1a with Arenes
(Benzene, o- and m-Xylenes, Anisole, Veratrole) under the
Action of FeCl3 (from ref 9)
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alcohols 1 results in formation of CF3-allyl cations A, having
two resonance forms, A′ and A″, with cationic centers on atoms
C2 and C4, respectively. Because of the electron-withdrawing
character of the CF3 group. these allyl cations react with arenes
through form A″ to form a new C−C bond at C4 carbon.
Intermediates B or C also possess highly electrophilic
properties and may participate in reactions.
To study this reaction deeper and ﬁnd its scope and
limitations, we decided to investigate a set of CF3-allyl alcohols
1a−f, bearing various substituents in the aromatic ring (Figure
2) and arenes. Also, we performed a theoretical investigation
(DFT calculations) of intermediate species A, B, C to have
their electronic characteristics. It should be noted that one of
the most important transformations of allyl cations10 is their
participation in new carbon−carbon bond forming processes by
reactions with arenes,11 heteroarenes,12 alkenes,13 alkynes,14 or
carbonyl compounds.15 To our surprise, reactions of triﬂuor-
omethylated allyl cations with C-nucleophiles have not been
widely described yet. Structurally related methyl allyl alcohols,
bearing a CH3 group instead of a CF3 one, in reactions with
(hetero)arenes under the action of Brønsted or Lewis acids
aﬀord Friedel−Crafts alkylation products exclusively (predom-
inantly, in some cases) at the C2 carbon (see Scheme
2).11a,f,g,12a−c We expected that introduction of the strong
acceptor CF3 group would signiﬁcantly change the reactivity of
such allyl systems compared to previously studied CH3-allyl
alcohols.
The main goal of this work was to investigate the reaction of
CF3-allyl alcohols 1a−f with various arenes under action of
Lewis acid FeCl3 or some Brønsted superacids. We expected
that electrophilic species formed from alcohols 1 in the
presence of acids will react with arenes to exhibit at least three
types of reaction routes. Three synthons which can describe the
chemistry of studied triﬂuoromethylated allyl alcohols 1 are
given in Figure 2. They are cationic and dicationic species
which are expected to have interesting and rich chemical
properties.
■ RESULTS AND DISCUSSION
To estimate electronic properties of reaction intermediates, we
performed DFT calculations of species A, B, and C, derived
from starting alcohols 1a−f (Table 1). Charge distribution,
contribution of the atomic orbital into the molecular orbital,
and global electrophilicity indices ω16 were calculated. Because
of the electron-withdrawing eﬀect of the CF3 group, cations
A1−A6 bear a greater positive charge on the carbon C4
compared to C2 (Table 1). Apart from that, atom C4 has a
larger LUMO contribution (31−35%). These data indicate a
coincidence of charge and orbital control in reactivity of carbon
C4 in cations A. Species B and C are characterized by a small
positive charge on atom C2 and a negative one on C4. The
LUMO of B is localized mainly on the iron atom (see the
Supporting Information). A higher contribution to the LUMO
at carbon C4 compared to C2 is observed for species C.
Therefore, charge controlled reactions of species B and C
should direct nucleophiles at carbon C2. Among these three
types of species, the cations A possess the highest electrophilic
properties based on the ω values of 14.1−19.9 eV in
comparison with ω = 6.7−7.5 eV for B and ω = 2.9−3.3 eV
for C, correspondingly (Table 1). The latter may be considered
as weaker electrophiles. According to the results of DFT
calculations, cation A1 has an absolutely planar geometry.
Similarly, species B1 and C1 are almost planar (see the
Supporting Information). The C−O bond in intermediate C1
is signiﬁcantly elongated (1.636 Å) compared to a normal C−O
bond in alcohols (1.43 Å). In the case of B1, the C−O bond is
only by 0.03 Å longer (1.464 Å) than that in the usual case.
Thus, the obtained calculated data revealed that the atom C4
must be the most reactive center in allyl cations A; on the
contrary, species B and C should react with nucleophiles with
attack to the C2 center. In other words, in the ﬁrst case, the
reaction may occur as an SN1′ process, but in the cases of
species B and C, most probably, the reaction should result in
the formation of products without an allylic rearrangement.
Therefore, reaction conditions (temperature and polarity of
solvent) can inﬂuence signiﬁcantly the direction of the reaction
to give diﬀerent types of products.
Having the results of theoretical prediction in hand, we
started the investigation of synthetic possibilities of the reaction
and their mechanism. FeCl3-promoted reaction of CF3-allyl
alcohols 1 with benzene, isomeric xylenes, anisole, and veratrole
gave highly regioselectively and stereoselectively CF3-alkenes 2
(Table 2, and Scheme 3). The reaction proceeds as an SN1′-
type process to form a new C−C bond at the C4 position of the
starting alcohol. That can be explained by the electron-
withdrawing action of the triﬂuoromethyl group making the
Scheme 2
Figure 2. CF3-alcohols 1a−f used in this study and their expected acid-
promoted reactivity.
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more preferable resonance form A″ (Scheme 1). It should be
noted that this reaction is 100% diastereoselective to form E-
isomers 2 only (conﬁgurations were conﬁrmed by NOESY; see
the Supporting Information). In 1H NMR, values of constants
3J between protons at the carbon−carbon double bond are
15.6−15.7 Hz, which correspond to the E-conﬁguration. This
stereochemical result can be explained by high steric demand of
both the diarylmethyl group and the triﬂuoromethyl moiety
attached to the formed double bond.
Methoxy substituted alcohols 1e,f aﬀorded complex mixtures
of oligomeric products in the same reactions under action of
FeCl3 (at r.t.) or Brønsted superacid TfOH (at r.t. or −35 °C).
It probably happened due to high π-nucleophilicity of
Table 1. Selected Electronic Characteristics and Calculated Geometries of Species A, B, and C
species R in Ar EHOMO, eV ELUMO, eV ω,
a eV q(C2),b e q(C4),b e k(C2) LUMO,c % k(C4) LUMO,c %
A1 H −12.18 −8.75 16.0 −0.05 0.09 24 35
A2 3-Me −11.71 −8.60 16.6 −0.06 0.10 23 35
A3 4-Me −11.89 −8.43 14.9 −0.07 0.08 21 32
A4 4-Cl −11.88 −8.66 16.4 −0.06 0.08 21 31
A5 3-MeO −10.96 −8.56 19.9 −0.10 0.10 23 34
A6 4-MeO −11.88 −8.01 14.1 −0.09 0.04 23 35
B1 H −7.12 −4.57 6.7 0.02 −0.11 d d
B2 3-Me −7.00 −4.54 6.8 0.02 −0.11 d d
B3 4-Me −6.88 −4.52 6.9 0.02 −0.11 d d
B4 4-Cl −7.10 −4.64 7.0 0.02 −0.11 d d
B5 3-MeO −6.69 −4.52 7.3 0.02 −0.11 d d
B6 4-MeO −6.50 −4.48 7.5 0.02 −0.11 d d
C1 H −7.23 −2.95 3.0 0.04 −0.04 8 25
C2 3-Me −7.11 −2.87 2.9 0.05 −0.04 17 12
C3 4-Me −7.03 −3.11 3.3 0.04 −0.02 18 22
C4 4-Cl −7.13 −3.00 3.1 0.04 −0.04 14 20
C5 3-MeO −6.70 −2.88 3.0 0.05 −0.04 13 13
C6 4-MeO −6.61 −2.92 3.1 0.04 −0.03 9 19
aGlobal electrophilicity index ω = (EHOMO + ELUMO)
2/8(ELUMO − EHOMO).
bNatural charges. cContribution of atomic orbital into the molecular
orbital. dLUMO is mainly localized on iron atom.
Table 2. Reaction of CF3-allyl Alcohols 1 with Arenes, Leading to CF3-alkenes 2
starting materials reaction products, E-2
entry alcohol 1 (R in Ar) arene, R′ conditionsa N R R′ isolated yield, %
1 1a (R = H) H A 2a H H 65
2 1a (R = H) 1,2-diMe A 2b H 3,4-diMe 75
3 1a (R = H) 1,3-diMe A 2c H 2,4-diMe 56
4 1a (R = H) MeO A 2d+2e (4/1) H MeO 72b
5 1a (R = H) 1,2-diMeO A 2f H 3,4-diMeO 48
6 1b (R = 3-Me) 1,2-diMe A 2g 3-Me 3,4-diMe 47
7 1d (R = 4-Cl) H A 2h 4-Cl H 42
8 1d (R = 4-Cl) 1,3-diMe A 2i 4-Cl 2,4-diMe 56
9 1d (R = 4-Cl) 1,2-diMeO A 2j 4-Cl 3,4-diMeO 43
10 1e (R = 3-MeO) H B 2k 3-MeO H 45
11 1e (R = 3-MeO) MeO B 2l + 2m(8/1) 3-MeO MeO 63b
aReactions conditions: A - FeCl3, CH2Cl2, 20 °C, 1 h, molar ratio 1:FeCl3:ArH = 1:1:1.1; B - FSO3H, CH2Cl2, −75 °C, 2 h, molar ratio
1:FSO3H:ArH = 1:80:3.
bMixture of para- (2d, 2l) and ortho- (2e, 2m) isomers was formed.
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.5b01398
J. Org. Chem. 2015, 80, 9506−9517
9508
methoxylated aromatic rings trapping intermediate cationic
species and leading the reaction into alternative routes at these
conditions. We managed to involve CF3-allyl alcohols 1e,f in
the reaction with arenes only at low temperature −75 °C in
superacid FSO3H (entries 10, 11, and see Scheme 6).
To check our hypothesis about the possibility to redirect the
reaction, we studied more carefully the reaction with more
nucleophilic arenes (xylenes, pseudocumene, and mesitylene)
and thiophene. Surprisingly, in the case of FeCl3 activation
reaction of alcohols 1a,d with para-xylene, we observed not
only formation of alkenes 2n,o but also of CF3-indanes 3a,b,
which were isolated as minor products (Scheme 3). The
corresponding triﬂuoromethylated indanes were isolated as cis-
isomers; their conﬁguration was established using NOESY
correlations (Figure 3).
The appearance of compounds 3 reveals the participation of
carbon C2 from the initial CF3-alcohols 1 (see Scheme 3) in
reaction with such π-donating arenes. The formation of indanes
3 can be explained by a two-step electrophilic substitution at
the para-xylene ring. The ﬁrst step of the reaction is the
formation of an allyl substituted arene; however, this is not the
alkene 2 because our additional experiments showed that
alkenes 2 cannot be cyclized to indanes 3 due to electron-
withdrawing destabilization of the formed carbocation by the
triﬂuoromethyl group (Scheme 8). It is quite interesting that, in
this reaction, triﬂuoromethylated alcohols perform as 1,3-
dicationic synthons.
The indane (indene) fragment is a very important structural
unit of a large number of bioactive and pharmaceutically
interesting molecules as well as modern catalysts for polymer-
ization. 2-Triﬂuoromethylated indanes are an important type of
indane derivatives, which have shown diﬀerent biological
activities: antiemetic (neurokinin receptor type 1 agonist)17a
and anticancer (pyruvate dehydrogenase kinase (PDHK)
inhibitor,17b growth factor receptor tyrosine kinase inhib-
itor17c). Apart from that, recently, we have shown that the trans-
1,3-diaryl-1-triﬂuoromethyl indane scaﬀold is a new core for
cannabinoid receptor ligand design.17d However, so far, the
existing approaches to triﬂuoromethylated indanes have some
restrictions.18 The synthesis proposed in this investigation is
quite straightforward to construct highly desirable CF3-indanes
3 from CF3-alcohols 1 and arene in a one-pot sequence.
The reaction of 1b with para- and meta-xylenes provided
exclusively the corresponding triﬂuoromethylated indanes in
moderate yields (Scheme 4). In the case of para-xylene, we
observed stereoselective formation of indane 3c having a cis-
conﬁguration, whereas, in the case of meta-xylene, a mixture of
cis-/trans-isomers 3d in the ratio of 1:3 was formed. These
stereochemical observations can be explained by the more
hindered structure of 3c, having an additional methyl group in
position 4 of the indane core.
More striking results were obtained with highly nucleophilic
pseudocumene and mesitylene (Scheme 5). Alcohols 1a−d
gave in the reaction with pseudocumene exclusively cis-indanes
3e−h. Reactions with mesitylene led to cis-, trans-indanes 3e,g,h
(Scheme 5). Formation of these types of indanes showed that a
shift of the methyl group in the mesitylene ring takes place
(Scheme 5). These results can be explained by protonation of
intermediate alkene D; the next step is electrophilic cyclization
in cation E, followed by migration of methyl group in species F
and elimination of a proton from the aryl ring, leading ﬁnally to
indanes 3.
Analogously to FeCl3-promoted synthesis of indanes
(Schemes 3−5), alcohol 1f can be activated with ﬂuorosulfonic
acid to form in the reaction with pseudocumene stereo-
selectively only cis-indane 3i (Scheme 6). The reaction depends
signiﬁcantly on the reactivity and nature of the aromatic
substrate. For example, in the case of reaction with anisole, we
observed no formation of indane. Two products 2p and 4a
(Scheme 6) were isolated. The ﬁrst step of the reaction in the
case of 4a is participation of atom C2. However, 2p is the result
of attack of anisole at C4 atom. These observations can be
explained by the higher polarization of the anisole molecule
having a nonactivated meta-position for electrophilic sub-
stitution; therefore, the formation of noncyclized products is
more favorable in this case.
Scheme 3
Figure 3. Selected NOESY correlations for cis- and trans-indanes 3
(blue: H-H correlations; green: H-F correlations).
Scheme 4
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Stereochemical structures of cis- and trans-indanes 3a−i were
determined by NOESY correlations (Figure 3). To have the
ﬁnal conﬁrmation of the conﬁguration, X-ray data for a single
crystal of compound cis-3g were obtained (Figure 4). 1H NMR
spectra can be also used to determine the conﬁguration. Proton
H3 of cis-isomers 3 has a resonance signal at 4.48−4.55 ppm as
a doublet with J 10.2−10.6 Hz; the same proton of trans-
isomers appears as a pseudotriplet at 4.56−4.60 ppm with J
8.6−8.7 Hz. Despite the predominant formation of cis-isomers
3, DFT calculations have shown that the diﬀerences between
Gibbs energies of cis- and trans-isomers 3a and 3d are 6.4 and
9.6 kJ/mol, correspondingly, in favor of the trans-isomers (see
the Supporting Information). Therefore, the formation of cis-
indanes is a kinetically controlled process.
We also studied the FeCl3-promoted reaction of CF3-
alcohols 1 with thiophene (Scheme 7). It is well-known that
thiophene is highly activated toward electrophiles and also
rather stable in acidic media compared to other ﬁve-membered
heterocycles. Another important feature of thiophene chemistry
is connected with the signiﬁcant strain that appeared when an
additional ﬁve-membered ring is condensed with the thiophene
fragment, making such a reaction unfavorable.19 Therefore, we
expected the absence of indane formation in the case of the
reaction with thiophene.
This assumption was found in very good agreement with
experiment. When the ratio of alcohols 1 and thiophene was 1
to 1, mixtures of mono-5 and bis-alkylated products 6 were
formed in good total yield (Scheme 7). The reaction proceeds
highly stereoselectively and regioselectively in terms of
thiophene substitution (only electrophilic substitution in the
α-position is observed) and alcohols 1 (reaction at C4 carbon).
Scheme 5
Scheme 6
Figure 4. Molecular structure of cis-3g (ellipsoid contour of
probability levels is 50%).
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Structures of compounds 5 and 6 prove that the C4 atom of
resonance form A″ (Scheme 2) takes part in alkylation. The
reaction can be performed more selectively to provide
exclusively either compound 5 or 6. For example, the reaction
of 1d with an excess of thiophene (5 equiv) gave selectively
only 5d, but in the case of the use of 0.5 equiv of thiophene,
adduct 6d was obtained solely (Scheme 7). The E-conﬁguration
of double bonds in alkenes 5 or 6 was conﬁrmed by NMR (see
the Supporting Information). It should be noted that
compounds 6 may be formed as mixtures of meso- and d,l-
isomers, but it is diﬃcult to determine their ratio due to
overlapping of signals of isomers in 1H and 19F NMR spectra
(see the Supporting Information).
Summarizing the discussed reactions (Table 2, Schemes
3−7), one may conclude that acid-promoted reaction of
alcohols 1 with arenes can proceed by several pathways with
participation of both reactive centers at carbons C4 and/or C2
(Scheme 1). Formation of indanes 3 (Schemes 3−6) and
products of double arylation 4a (Scheme 6) reveal the
participation at the ﬁrst step of the reaction of atom C2 of
starting alcohol 1. Alkylation of arenes (Table 2, Scheme 3) and
thiophene (Scheme 7) may be explained through intermediate
generating of an allyl cation reacting highly predominantly at
atom C4 (Scheme 2). However, involvement of atom C2 in
reactions may prove that species other than A also take part in
these transformations. Most probably these particles have
structures B and C (Scheme 2), derived from alcohols 1 under
coordination of FeCl3 on hydroxyl group oxygen or by
protonation of this oxygen. Indeed, it should be diﬃcult to
eliminate the hydroxyl group from initial alcohol 1 to generate
allyl cation A due to powerful electron-withdrawing properties
of group CF3. Intermediates B and C may participate in the
reaction medium and react with rather nucleophilic electron
rich arenes.
On the basis of experimental results and theoretical
calculations, we proposed a possible reaction mechanism
including multiple pathways of CF3-allyl alcohols 1 with arenes
under action of Lewis or Brønsted acids (Scheme 8). Species B
and C, having enough electrophilic center on C2, react with
rather π-donating arenes, such as xylenes, pseudocumene, and
mesitylene, forming compounds D. Further protonation of the
formed alkene leads to cation E (Scheme 8), which may react
in two diﬀerent pathways. The ﬁrst direction is intramolecular
cyclization into indanes 3. This route is realized when the
adjacent ortho-position is quite reactive. Another pathway is the
reaction with one more arene molecule, leading to compounds
4 (Scheme 8). It should be noted that compounds 2 in FeCl3-
or FSO3H-promoted reactions are not cyclized into indanes 3
and do not give 4 with arenes, due to deactivation of the double
bond to protonation in alkenes 2 by the electron-withdrawing
CF3 group. Directions of all of these transformations of
alcohols 1 into diﬀerent products 2−4 depend on the
electrophilicity of species A, B, C and nucleophilicity of arenes.
In some cases, mixed mechanism can be realized, for example,
the reaction of 1 with para-xylene, giving mixtures of
compounds 2 and 3 (Scheme 3).
■ CONCLUSIONS
In conclusion, we have studied the acid-promoted reaction of 4-
aryl-1,1,1-triﬂuorobut-3-en-2-ols (CF3-allyl alcohols) with
arenes. It was found that the most eﬃcient activators of this
reaction are anhydrous FeCl3 and FSO3H. The reaction aﬀords
eﬃcient stereoselective synthesis of triﬂuoromethylated alkenes
(up to 75%) and indanes (up to 81%): only E-CF3-alkenes and
predominantly cis-CF3-indanes are formed. Short reaction
times, good yields, and simplicity of the reaction procedure
are signiﬁcant advantages of the method. A possible reaction
mechanism includes three types of electrophilic species derived
from starting alcohols. The formation of two types of reaction
Scheme 7
Scheme 8. Possible Mechanism of Acid-Promoted Reaction of 1 with Arenes
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products depends on the nucleophilicity of arene and the
electrophilicity of cationic intermediates, generated from CF3-
allyl alcohols under reaction conditions.
■ EXPERIMENTAL SECTION
The NMR spectra of solutions of compounds in CDCl3 were recorded
at 400, 376, and 100 MHz for 1H, 19F, and 13C NMR, respectively, at
25 °C. The residual proton-solvent peak CDCl3 (δ 7.26 ppm) for
1H
NMR spectra and the carbon signal of CDCl3 (δ 77.0 ppm) for
13C
NMR spectra were used as references. Chromato-mass-spectrometry
data were obtained at a capillary column (30 m × 0.32 mm), with the
thickness of the stationary phase being 1.25 μm. The preparative
reactions were monitored by thin-layer chromatography carried out on
silica gel plates, using UV light for detection. Preparative TLC was
performed on silica gel (5−40 μm) with a petroleum ether−ethyl
acetate mixture eluation.
A suitable crystal was selected and studied on the diﬀractometer for
X-ray analysis. The crystal was kept at 100(2) K during data collection.
Using Olex2,20 the structure was solved with the ShelXS20 structure
solution program using direct methods and reﬁned with the ShelXL
reﬁnement package using least-squares minimization. CCDC 1406002
(cis-3g) contain the supplementary crystallographic data, which can be
obtained free of charge at www.ccdc.cam.ac.uk/conts/retrieving.htmL
or from the Cambridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, U.K.; Fax: (internat.) + 44-1223-336-033; E-
mail: deposit@ccdc.cam.ac.uk.
All computations has been carried out at the DFT/HF hybrid level
of theory using Becke’s three-parameter hybrid exchange functional in
combination with the gradient-corrected correlation functional of Lee,
Yang, and Parr (B3LYP) by using Gaussian 2003 program packages.21
The geometries optimization were performed using the 6-311+G-
(2d,2p) basis set The Hessian matrix was calculated analytically for the
optimized structures in order to prove the location of correct minima
(no imaginary frequencies) and to estimate the thermodynamic
parameters. Enthalpies and Gibbs free energies were calculated for 25
°C.
Starting 4-Aryl-1,1,1-truﬂuorobut-3-en-2-ols (1a−f). The title
compounds were obtained by carbonyl reduction of the corresponding
4-aryl-1,1,1-triﬂuorobut-3-en-2-ones according to the known proce-
dure.22 The properties of compounds 1a,c,d were given in our
preliminary communication.9 Their NMR data matched those
previously reported.23
(E)-1,1,1-Triﬂuoro-4-(3-methylphenyl)but-3-en-2-ol (1b). Yield
288 mg, 96%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ, ppm:
2.34 (br. s, 1H, OH), 2.36 (s, 3H, CH3), 4.63 (pseudo-quintet d, 1H, J
= 6.6 Hz, JH‑F = 6.6 Hz, J = 1.0 Hz), 6.19 (dd, 1H, J = 16.0 Hz, J = 6.6
Hz), 6.83 (d, 1H, J = 16.0 Hz), 7.12−7.14 (m, 1H), 7.22−7.27 (m,
3H). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.4 (CH3), 71.8 (q, C
2,
JC‑F = 32.3 Hz), 120.6 (q, C
3, JC‑F = 1.7 Hz), 124.4 (q, C
1, JC‑F = 281.9
Hz), 124.2, 127.7, 128.8, 129.7, 135.4, 136.6 (C4), 138.5. 19F NMR
(CDCl3, 376 MHz) δ, ppm: −79.07 (d, CF3, JH‑F = 6.6 Hz). HRMS
(ESI): C11H12F3O found 217.0837 [M + H]
+; calcd. 217.0840.
(E)-1,1,1-Triﬂuoro-4-(3-methoxyphenyl)but-3-en-2-ol (1e). Yield
280 mg, 93%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ, ppm: 2.48
(br. s, 1H, OH), 3.84 (s, 3H, CH3), 4.64 (pseudo-quintet d, 1H, J =
6.5 Hz, JH‑F = 6.5 Hz, J = 0.8 Hz), 6.21 (dd, 1H, J = 15.9 Hz, J = 6.5
Hz), 6.84 (d, 1H, J = 15.9 Hz), 6.87−7.30 (m, 4H). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 55.4 (CH3), 71.7 (q, C
2, JC‑F = 32.3 Hz),
112.8, 114.6, 119.7, 121.1 (C3), 124.4 (q, C1, JC‑F = 281.8 Hz), 129.9,
136.3 (C4), 136.9, 160.0. 19F NMR (CDCl3, 376 MHz) δ, ppm:
−79.04 (d, CF3, JH‑F = 6.5 Hz). HRMS (ESI): C11H12F3O2 found
233.0811 [M + H]+; calcd. 233.0789.
(E)-1,1,1-Triﬂuoro-4-(4-methoxyphenyl)but-3-en-2-ol (1f).24 Yield
300 mg, 99%. Colorless solid, mp 38−40 °C. 1H NMR (CDCl3, 400
MHz) δ, ppm: 2.45 (br. s, 1H, OH), 3.82 (s, 3H, CH3), 4.64 (pseudo-
quintet, 1H, J = 6.5 Hz, JH‑F = 6.5 Hz), 6.06 (dd, 1H, J = 15.9 Hz, J =
6.5 Hz), 6.78 (d, 1H, J = 15.9 Hz), 6.86−6.90 (m, 2H), 7.34−7.37 (m,
2H). 19F NMR (CDCl3, 376 MHz) δ, ppm: −79.10 (d, CF3, JH‑F = 6.5
Hz).
General Procedure for the Reaction of 1 with Arenes and
Thiophene under Action of FeCl3. Synthesis of 2, 3, 5, and 6.
Anhydrous FeCl3 (0.3 mmol) was added to a solution of alcohol 1 (0.3
mmol) and arene (0.32 mmol) or thiophene (0.34 mmol) in
anhydrous dichloromethane (1 mL). The mixture was stirred at
room temperature for 1 h and then quenched with a saturated aqueous
solution of NH4Cl. The aqueous layer was extracted with CHCl3 (2 ×
50 mL), and the combined organic layers were dried over Na2SO4 and
concentrated under reduced pressure. The crude mixture was puriﬁed
by preparative TLC on silica gel, using petroleum ether or petroleum
ether−EtOAc mixtures (95:5 to 9:1) as an eluent.
General Procedure for the Reaction of 1 with Arenes in
FSO3H. Synthesis of 2, 3, 4. Alcohol 1 (0.26 mmol) was added to
mixture of FSO3H (at −75 °C) (1 mL), CH2Cl2 (1−3 mL) with
benzene (0.69 mL), or another arene (0.28 mmol). The reaction
mixture was magnetically stirred for 2 h. The reaction mixture was
poured into frozen concentrated aqueous HCl (10 mL), diluted with
water (20 mL), and then extracted with chloroform (2 × 40 mL). The
extracts were combined, washed with water, a saturated aqueous
solution of NaHCO3, and water again, and dried over Na2SO4. The
solvent was distilled oﬀ under reduced pressure. The crude mixture
was puriﬁed by preparative TLC on silica gel, using petroleum ether−
EtOAc mixtures (9:1) as an eluent.
(E)-1,1,1-Triﬂuoro-4,4-diphenylbut-2-ene (2a).9 In this case, the
reaction was performed with the compound 1a (0.3 mmol) and
benzene (14.8 mmol). Yield 50 mg, 65%. Colorless oil. 1H NMR
(CDCl3, 400 MHz) δ, ppm: 4.84 (dqd, 1H, J = 6.8 Hz, J = 1.6 Hz, JH‑F
= 2.0 Hz), 5.50 (dqd, 1H, C2H, J = 15.6 Hz, JH‑F = 6.4 Hz, J = 1.6 Hz),
6.87 (ddq, 1H, J = 15.6 Hz, J = 6.8 Hz, JH‑F = 2.0 Hz), 7.16−7.36 (m,
10H). 19F NMR (CDCl3, 376 MHz) δ, ppm: −63.70 (dt, CF3, JH‑F =
6.4 Hz, JH‑F = 2.0 Hz).
(E)-1,1,1-Triﬂuoro-4-(3,4-dimethylphenyl)-4-phenylbut-2-ene
(2b).9 Yield 64 mg, 75%. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 2.26 (s, 6H, 2CH3), 4.78 (m, 1H), 5.52 (dqd, 1H, J = 15.6 Hz,
JH‑F = 6.4 Hz, J = 1.7 Hz), 6.88 (ddq, 1H, J = 15.6 Hz, J = 6.8 Hz, JH‑F
= 2.0 Hz), 6.90−6.92 (m, 1H), 6.95 (s, 1H), 7.11 (d, 1H, J = 7.6 Hz),
7.17−7.19 (m, 2H), 7.25−7.36 (m, 3H). 19F NMR (CDCl3, 376
MHz) δ, ppm: −63.60 (dt, CF3, JH‑F = 6.4 Hz, JH‑F = 2.0 Hz).
(E)-1,1,1-Triﬂuoro-4-(2,4-dimethylphenyl)-4-phenylbut-2-ene
(2c).9 Yield 48 mg, 56%. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 2.22 (s, 3H, CH3), 2.33 (s, 3H, CH3), 4.98 (m, 1H), 5.36 (dqd,
1H, J = 15.6 Hz, JH‑F = 6.4 Hz, J = 1.8 Hz), 6.87 (ddq, 1H, J = 15.6 Hz,
J = 6.0 Hz, JH‑F = 2.0 Hz), 6.95−7.03 (m, 3H), 7.11−7.13 (m, 2H),
7.24−7.34 (m, 3H). 19F NMR (CDCl3, 376 MHz) δ, ppm: −63.53
(dt, CF3, JH‑F = 6.4 Hz, JH‑F = 2.0 Hz).
(E)-1,1,1-Triﬂuoro-4-(4-methoxyphenyl)-4-phenylbut-2-ene (2d).9
Yield 50 mg, 58%. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ, ppm:
3.80 (s, 3H, CH3), 4.79−4.81 (m, 1H), 5.49 (dqd, 1H, J = 15.6 Hz,
JH‑F = 6.4 Hz, J = 1.6 Hz), 6.85 (ddq, 1H, J = 15.6 Hz, J = 6.4 Hz, JH‑F
= 2.0 Hz), 6.89 (d, 2H, J = 8.5 Hz), 7.08 (d, 2H, J = 8.5 Hz), 7.16 (d,
2H, J = 7.2 Hz), 7.24−7.36 (m, 3H). 19F NMR (CDCl3, 376 MHz) δ,
ppm: −63.63 dt (CF3, JH‑F = 6.4 Hz, JH‑F = 2.0 Hz).
(E)-1,1,1-Triﬂuoro-4-(2-methoxyphenyl)-4-phenylbut-2-ene (2e).9
Yield 12 mg, 14%. Pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 3.78 (s, 3H, CH3), 5.25−5.26 (m, 1H), 5.44 (dqd, 1H, J = 15.6
Hz, JH‑F = 6.4 Hz, J = 1.5 Hz), 6.85 (ddq, 1H, J = 15.6 Hz, J = 6.4 Hz,
JH‑F = 2.0 Hz), 6.88−6.95 (m, 2H), 7.04 (dd, 1H, J = 7.5 Hz, J = 1.3
Hz), 7.16−7.18 (m, 2H), 7.22−7.33 (m, 4H). 19F NMR (CDCl3, 376
MHz) δ, ppm: −63.55 (dt, CF3, JH‑F = 6.4 Hz, JH‑F = 2.0 Hz).
(E)-1,1,1-Triﬂuoro-4-(3,4-dimethoxyphenyl)-4-phenylbut-2-ene
(2f).9 Yield 46 mg, 48%. Colorless solid, mp 67−68 °C (MeOH). 1H
NMR (CDCl3, 400 MHz) δ, ppm: 3.82 (s, 3H, CH3), 3.87 (s, 3H,
CH3), 4.79 (m, 1H), 5.50 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.3 Hz, J = 1.2
Hz), 6.65 (d, 1H, J = 1.6 Hz), 6.70 (dd, 1H, J = 8.2 Hz, J = 1.6 Hz),
6.84 (d, 1H, J = 8.2 Hz), 6.84 (ddq, 1H, J = 15.6 Hz, J = 6.8 Hz, JH‑F =
2.0 Hz), 7.16 (d, 2H, J = 7.2 Hz), 7.25−7.36 (m, 3H). 19F NMR
(CDCl3, 376 MHz) δ, ppm: −63.63 dt (CF3, JH‑F = 6.3 Hz, JH‑F = 2.0
Hz).
(E)-1,1,1-Triﬂuoro-4-(3,4-dimethylphenyl)-4-(3-methylphenyl)-
but-2-ene (2g). Yield 46 mg, 48%. Pale yellow oil. 1H NMR (CDCl3,
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400 MHz) δ, ppm: 2.25 (s, 6H, 2CH3), 2.33 (s, 3H, CH3), 4.72−4.73
(m, 1H), 5.51 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.4 Hz, J = 1.2 Hz), 6.85
(ddq, 1H, J = 15.6 Hz, J = 6.7 Hz, JH‑F = 2.0 Hz), 6.89−6.90 (m, 1H),
6.93 (s, 1H), 6.96−6.98 (m, 1H), 6.98 (s, 1H), 7.07 (d, 1H, J = 7.7
Hz), 7.10 (d, 1H, J = 7.7 Hz), 7.22 (t, 1H, J = 7.7 Hz). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 19.5 (CH3), 20.0 (CH3), 21.6 (CH3),
52.5 (C4), 120.1 (q, C2, JC‑F = 33.4 Hz), 123.4 (q, C
1, JC‑F = 269.5 Hz),
125.6, 126.0, 127.9, 128.7, 129.3, 129.9, 130.1, 135.5, 137.1, 138.5,
138.8, 141.5, 142.8 (q, C3, JC‑F = 6.3 Hz).
19F NMR (CDCl3, 376
MHz) δ, ppm: −63.58 (dt, CF3, JH‑F = 6.4 Hz, JH‑F = 2.0 Hz). MS
(GC−MS, EI), m/z, (Irel., %): 304 (80) [M]+, 289 (100), 269 (5), 235
(8), 212 (13), 197 (33), 179 (10), 165 (5), 144 (13), 129 (28), 110
(18), 91 (10), 77 (10), 51 (5). HRMS (ESI): C19H20F3 found
305.1514 [M + H]+; calcd. 305.1517.
(E)-4-(4-Chlorophenyl)-1,1,1-triﬂuoro-4-phenylbut-2-ene (2h).
Yield 30 mg, 42%. Pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 4.81−4.83 (m, 1H), 6.50 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.0 Hz, J
= 1.5 Hz), 6.83 (ddq, 1H, J = 15.6 Hz, J = 6.8 Hz, JH‑F = 2.0 Hz), 7.09
(d, 2H, J = 8.4 Hz), 7.14 (m, 2H), 7.27−7.37 (m, 5H). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 52.1 (C
4), 120.9 (q, C2, JC‑F = 33.6 Hz),
123.2 (q, C1, JC‑F = 269.7 Hz), 127.5, 128.6, 129.0, 129.1, 130.0, 133.2,
139.7, 140.7, 141.9 (q, C3, JC‑F = 6.3 Hz).
19F NMR (CDCl3, 376
MHz) δ, ppm: −63.77 (dt, CF3, JH‑F = 6.0 Hz, JH‑F = 2.0 Hz). MS
(GC−MS, EI), m/z, (Irel., %): 296/298 (25/9) [M]+, 261 (100), 241
(5), 221 (10), 183 (32), 165 (25), 149 (10), 133 (8), 115 (30), 91




2-ene (2i). Yield 46 mg, 56%. Pale yellow oil. 1H NMR (CDCl3, 400
MHz) δ, ppm: 2.18 (s, 3H, CH3), 2.32 (s, 3H, CH3), 4.93−4.94 (m,
1H), 5.34 (dqd, 1H, J = 15.8 Hz, JH‑F = 6.3 Hz, J = 1.7 Hz), 6.82 (ddq,
1H, J = 15.8 Hz, J = 5.9 Hz, JH‑F = 2.0 Hz), 6.91 (d, 1H, J = 8.3 Hz),
7.01 (m, 2H), 7.03 (d, 2H, J = 8.4 Hz), 7.29 (d, 2H, J = 8.4 Hz). 13C
NMR (CDCl3, 100 MHz) δ, ppm: 19.6 (CH3), 21.1 (CH3), 48.2 (C
4),
120.7 (q, C2, JC‑F = 33.6 Hz), 123.3 (q, C
1, JC‑F = 269.6 Hz), 127.2,
128.3, 129.0, 130.3, 132.0, 133.0, 135.8, 136.2, 137.2, 139.1, 142.3 (q,
C3, JC‑F = 6.3 Hz).
19F NMR (CDCl3, 376 MHz) δ, ppm: −63.61 (dt,
CF3, JH‑F = 6.3 Hz, JH‑F = 2.2 Hz). MS (GC−MS, EI), m/z, (Irel., %):
324/326 (83/28) [M]+, 309/311 (100/33), 289 (52), 274 (7), 255
(8), 212 (12), 197 (19), 178 (15), 144 (16), 125 (14), 101 (16), 77
(15), 51 (5). HRMS (ESI): C18H16F3Cl found 324.0895 M+; calcd.
324.0893.
(E)-4-(4-Chlorophenyl)-1,1,1-triﬂuoro-4-(3,4-dimethoxyphenyl)-
but-2-ene (2j). Yield 40 mg, 43%. Pale yellow oil. 1H NMR (CDCl3,
400 MHz) δ, ppm: 3.82 (s, 3H, CH3), 3.87 (s, 3H, CH3), 4.75−4.77
(m, 1H), 5.49 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.0 Hz, J = 1.5 Hz), 6.61
(d, 1H, J = 1.9 Hz), 6.67 (dd, 1H, J = 8.2 Hz, J = 1.9 Hz), 6.79 (ddq,
1H, J = 15.6 Hz, J = 6.4 Hz, JH‑F = 2.0 Hz), 6.84 (d, 1H, J = 8.2 Hz),
7.08 (d, 2H, J = 8.4 Hz), 7.31 (d, 2H, J = 8.4 Hz). 13C NMR (CDCl3,
100 MHz) δ, ppm: 51.6 (C4), 56.1 (CH3), 56.1 (CH3), 111.5, 111.9,
120.7 (q, C2, JC‑F = 38.6 Hz), 120.7, 123.2 (q, C
1, JC‑F = 269.6 Hz),
129.1, 130.0, 133.0, 133.1, 139.8, 142.1 (q, C3, JC‑F = 6.3 Hz), 148.4,
149.4. 19F NMR (CDCl3, 376 MHz) δ, ppm: −63.71 (dt, CF3, JH‑F =
6.0 Hz, JH‑F = 2.0 Hz). MS (GC−MS, EI), m/z, (Irel., %): 356/358
(100/36) [M]+, 341/343 (12/4), 325/327 (53/28), 321 (10), 287
(10), 261 (10), 213 (11), 165 (13), 138 (10), 107 (5), 89 (7), 51 (8).




Yield 34 mg, 45%. Pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 3.78 (s, 1H, CH3), 4.80−4.81 (m, 1H), 5.52 (dqd, 1H, J = 15.7
Hz, JH‑F = 6.3 Hz, J = 1.6 Hz), 6.70−6.71 (m, 1H), 6.76 (d, 1H, J = 8.6
Hz), 6.81 (dd, 1H, J = 8.6 Hz, J = 2.3 Hz), 6.88 (ddq, 1H, J = 15.7 Hz,
J = 6.4 Hz, JH‑F = 2.0 Hz), 7.16−7.18 (m, 2H), 7.24−7.27 (m, 2H),
7.32−7.35 (m, 2H). 13C NMR (CDCl3, 100 MHz) δ, ppm: 52.6 (C4),
55.19 (CH3), 112.0, 114.8, 120.4 (q, C
2, JC‑F = 33.6 Hz), 120.9, 123.2
(q, C1, JC‑F = 262.3 Hz), 127.1, 128.5, 128.8, 129.8, 140.9, 142.2 (q, C
3,
JC‑F = 6.4 Hz), 142.64, 159.9.
19F NMR (CDCl3, 376 MHz) δ, ppm:
−63.70 (dt, CF3, JH‑F = 6.3 Hz, JH‑F = 2.0 Hz). MS (GC−MS, EI), m/
z, (Irel., %): 292 (100) [M]
+, 277 (9), 261 (29), 253 (5), 223 (26), 209
(19), 184 (21), 165 (40), 152 (19), 145 (21), 115 (60), 91 (24), 77
(15), 63 (15), 51 (13). HRMS (ESI): C17H16F3O found 293.1155 [M
+ H]+; calcd. 293.1153.
(E)-1,1,1-Triﬂuoro-4-(3-methoxyphenyl)-4-(4-methoxyphenyl)-
but-2-ene (2l). Yield 47 mg, 56%. Pale yellow oil. 1H NMR (CDCl3,
400 MHz) δ, ppm: 3.78 (s, 3H, CH3), 3.80 (s, 3H, CH3), 4.75−4.77
(m, 1H), 5.50 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.0 Hz, J = 1.5 Hz), 6.69
(s, 1H), 6.75 (d, 1H, J = 7.9 Hz), 6.80 (dd, 1H, J = 7.9 Hz, J = 2.5 Hz),
6.79−6.86 (m, 1H), 6.87 (d, 2H, J = 8.7 Hz), 7.08 (d, 2H, J = 8.7 Hz),
7.25 (t, 1H, J = 7.9 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 52.0
(C4), 55.3 (CH3), 55.4 (CH3), 112.1, 114.3, 114.8, 120.3 (q, C
2, JC‑F =
33.4 Hz), 121.0, 123.3 (q, C1, JC‑F = 269.5 Hz), 129.7, 129.9, 133.1,
142.6 (q, C3, JC‑F = 6.3 Hz), 143.1, 158.8, 160.0.
19F NMR (CDCl3,
376 MHz) δ, ppm: −63.64 (dt, CF3, JH‑F = 6.0 Hz, JH‑F = 1.9 Hz). MS
(GC−MS, EI), m/z, (Irel., %): 322 (100) [M]+, 307 (7), 291 (35), 279
(5), 253 (15), 239 (20), 214 (26), 195 (9), 183 (10), 165 (8), 145
(48), 141 (5), 121 (18), 103 (5), 91 (6), 77 (7), 63 (5). HRMS (ESI):
C18H18F3O2 found 323.1257 [M + H]
+; calcd. 323.1259.
(E)-1,1,1-Triﬂuoro-4-(2-methoxyphenyl)-4-(3-methoxyphenyl)-
but-2-ene (2m). Yield 6 mg, 7%. Pale yellow oil. 1H NMR (CDCl3,
400 MHz) δ, ppm: 3.77 (s, 3H, CH3), 3.79 (s, 3H, CH3), 5.21−5.23
(m, 1H), 5.45 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.4 Hz, J = 0.8 Hz), 6.71
(s, 1H), 6.75−6.79 (m, 2H), 6.79−6.86 (m, 1H), 6.89 (d, 1H, J = 8.1
Hz), 6.93 (t, 1H, J = 7.6 Hz), 7.04 (d, 1H, J = 7.6 Hz), 7.22 (d, 1H, J =
8.1 Hz), 7.26 (m, 1H). 13C NMR (CDCl3, 100 MHz) δ, ppm: 45.7
(C4), 55.3 (CH3), 55.7 (CH3), 111.1, 111.9, 115.0, 120.0 (q, C
2, JC‑F =
33.3 Hz), 120.8, 121.2, 123.5 (q, C1, JC‑F = 269.5 Hz), 128.5, 129.4,
129.5, 129.6, 142.3 (q, C3, JC‑F = 6.4 Hz), 157.0, 159.8.
19F NMR
(CDCl3, 376 MHz) δ, ppm: −63.55 (dt, CF3, JH‑F = 6.4 Hz, JH‑F = 2.0
Hz). MS (GC−MS, EI), m/z, (Irel., %): 322 (100) [M]+, 307 (10), 291
(25), 271 (5), 251 (5), 239 (7), 225 (50), 214 (12), 197 (20), 181
(10), 165 (14), 145 (30), 131 (10), 121 (30), 107 (6), 91 (25), 77




(2n). Yield 40 mg, 47%. Colorless oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 2.19 (s, 3H, CH3), 2.31 (s, 3H, CH3), 4.97−4.98 (m, 1H), 5.37
(dqd, 1H, J = 15.6 Hz, JH‑F = 6.4 Hz, J = 1.2 Hz), 6.86 (ddq, 1H, J =
15.6 Hz, J = 6.0 Hz, JH‑F = 2.0 Hz), 6.87 (s, 1H), 7.01 (d, 1H, J = 7.8
Hz), 7.08 (d, 1H, J = 7.8 Hz), 7.36 (d, 2H, J = 7.4 Hz), 7.24−7.34 (m,
3H). 13C NMR (CDCl3, 100 MHz) δ, ppm: 19.3 (CH3), 21.3 (CH3),
49.1 (C4), 120.5 (q, C2, JC‑F = 33.4 Hz), 123.4 (q, C
1, JC‑F = 269.5 Hz),
127.1, 128.0, 128.8, 129.0, 129.1, 130.9, 133.3, 135.9, 139.1, 140.1,
142.8 (q, C3, JC‑F = 6.3 Hz).
19F NMR (CDCl3, 376 MHz) δ, ppm:
−63.52 (dt, CF3, JH‑F = 6.4 Hz, JH‑F = 2.0 Hz). MS (GC−MS, EI), m/
z, (Irel., %): 290 (86) [M]
+, 275 (100), 255 (6), 235 (6), 212 (25), 197
(24), 193 (20), 184 (26), 178 (31), 165 (20), 143 (22), 115 (40), 103
(20), 91 (35), 77 (20), 65 (8), 51 (10). HRMS (ESI): C18H18F3 found
291.1358 [M + H]+; calcd. 291.1361.
(E)-4-(4-Chlorophenyl)-1,1,1-triﬂuoro-4-(2,5-dimethylphenyl)but-
2-ene (2o). Yield 58 mg, 69%. Pale yellow oil. 1H NMR (CDCl3, 400
MHz) δ, ppm: 2.17 (s, 3H, CH3), 2.31 (s, 3H, CH3), 4.94−4.95 (m,
1H), 5.35 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.0 Hz, J = 1.2 Hz), 6.79−6.85
(m, 1H), 6.83 (s, 1H), 7.01−7.09 (m, 4H), 7.29 (d, 2H, J = 8.4 Hz).
13C NMR (CDCl3, 100 MHz) δ, ppm: 19.3 (CH3), 21.3 (CH3), 48.5
(C4), 120.8 (q, C2, JC‑F = 33.6 Hz), 123.3 (q, C
1, JC‑F = 269.5 Hz),
128.2, 128.9, 129.0, 130.3, 131.0, 133.0, 133.2, 136.0, 138.6, 139.0,
142.3 (q, C3, JC‑F = 6.2 Hz).
19F NMR (CDCl3, 376 MHz) δ, ppm:
−63.59 (dt, CF3, JH‑F = 6.0 Hz, JH‑F = 2.0 Hz). MS (GC−MS, EI), m/
z, (Irel., %): 324/326 (87/31) [M]
+, 309/311 (100/33), 289 (43), 274
(10), 255 (12), 240 (7), 212 (31), 197 (25), 192 (35), 178 (20), 149
(17), 143 (26), 128 (20), 115 (18), 101 (19), 77 (21), 65 (5), 51 (7).
HRMS (ESI): C18H17ClF3 found 325.0965 [M + H]
+; calcd. 325.0971.
(E)-1,1,1-Triﬂuoro-4-bis(4-methoxyphenyl)but-2-ene (2p). Yield
24 mg, 28%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ, ppm: 3.82
(s, 6H, CH3), 4.76−4.78 (m, 1H), 5.49 (dqd, 1H, J = 15.6 Hz, JH‑F =
6.4 Hz, J = 1.5 Hz), 6.85 (ddq, 1H, J = 15.6 Hz, J = 6.8 Hz, JH‑F = 2.1
Hz), 6.89 (d, 4H, J = 8.7 Hz), 7.09 (d, 4H, J = 8.7 Hz). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 51.2 (C
4), 55.4 (CH3), 114.2, 120.0 (q,
C2, JC‑F = 33.4 Hz), 123.4 (q, C
1, JC‑F = 269.6 Hz), 129.6, 133.6, 143.1
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(q, C3, JC‑F = 6.2 Hz), 158.7.
19F NMR (CDCl3, 376 MHz) δ, ppm:
−63.57 (dt, CF3, JH‑F = 6.4 Hz, JH‑F = 2.1 Hz). MS (GC−MS, EI), m/
z, (Irel., %): 322 (100) [M]
+, 307 (5), 291 (40), 253 (43), 227 (16),
214 (26), 183 (10), 165 (6), 145 (66), 121 (25), 91 (6), 77 (8), 63




3a). Yield 16 mg, 19%. Colorless solid, mp 101−103 °C (MeOH). 1H
NMR (CDCl3, 400 MHz) δ, ppm: 2.00 (s, 3H, CH3), 2.33−2.36 (m,
1H), 2.40 (s, 3H, CH3), 3.00 (dt, 1H, J = 14.4 Hz, J = 10.5 Hz), 3.89
(pseudo-quintet d, 1H, J = 9.7 Hz, JH‑F = 9.7 Hz, J = 1.5 Hz), 4.54 (dd,
1H, J = 10.5 Hz, J = 1.5 Hz), 7.08 (d, 2H, J = 7.3 Hz), 7.11 (s, 2H),
7.20 (t, 1H, J = 7.3 Hz), 7.28 (m, 2H). 13C NMR (CDCl3, 100 MHz)
δ, ppm: 19.2 (CH3), 20.0 (q, CH3, JC‑F = 3.6 Hz), 35.4 (q, C
2, JC‑F =
2.0 Hz), 47.9 (q, C1, JC‑F = 28.8 Hz), 48.6 (C
3), 126.2, 127.6 (q, CF3,
JC‑F = 280.2 Hz), 128.0, 128.3, 130.0, 130.6, 133.2, 133.8, 136.5 (q, JC‑F
= 1.8 Hz), 144.0, 145.0. 19F NMR (CDCl3, 376 MHz) δ, ppm: −66.71
(d, CF3, JH‑F = 9.7 Hz). MS (GC−MS, EI), m/z, (Irel., %): 290 (50)
[M]+, 275 (100), 197 (10), 178 (5), 143 (10), 115 (15), 89 (12).




indane (cis-3b). Obtained in a mixture with alkene 2o (2o:cis-3b,
1.6:1). Yield 8 mg, 10%. Pale yellow oil. 1H NMR (CDCl3, 400 MHz)
δ, ppm: 1.97 (s, 3H, CH3), 2.25−2.30 (m, 1H), 2.37 (s, 3H, CH3),
2.97 (dt, 1H, J = 14.4 Hz, J = 10.4 Hz), 3.86 (pseudo-quintet d, 1H, J
= 9.7 Hz, JH‑F = 9.7 Hz, J = 1.4 Hz), 4.48 (d, 1H, J = 10.4 Hz), 6.98 (d,
2H, J = 8.4 Hz), 7.09 (s, 2H), 7.22 (d, 2H, J = 8.4 Hz). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 19.2 (CH3), 20.0 (q, CH3, JC‑F = 3.6 Hz),
35.3 (q, C2, JC‑F = 1.9 Hz), 47.8 (q, C
1, JC‑F = 28.8 Hz), 47.9 (C
3),
127.6 (q, CF3, JC‑F = 280.3 Hz), 128.2, 129.4, 130.2, 130.7, 131.9,
133.0, 133.9, 136.4 (q, JC‑F = 2.0 Hz), 142.5, 144.5.
19F NMR (CDCl3,
376 MHz) δ, ppm: −66.78 (d, CF3, JH‑F = 9.7 Hz). MS (GC−MS, EI),
m/z, (Irel., %): 324/326 (55/19) [M]
+, 309/311 (100/35), 289 (30),
274 (5), 255 (7), 212 (10), 197 (8), 178 (5), 149 (5), 143 (10), 128
(11), 110 (6), 101 (15). HRMS (ESI): C18H17ClF3 found 325.0965
[M + H]+; calcd. 325.0971.
rel-(1S,3S)-1-(Triﬂuoromethyl)-4,7-dimethyl-3-(3-methylphenyl)-
indane (cis-3c). Yield 24 mg, 28%. Colorless oil. 1H NMR (CDCl3,
400 MHz) δ, ppm: 1.98 (s, 3H, CH3), 2.29−2.33 (m, 1H), 2.30 (s,
3H, CH3), 2.38 (s, 3H, CH3), 2.97 (dt, 1H, J = 14.4 Hz, J = 10.5 Hz),
3.86 (pseudo-quintet d, 1H, J = 9.7 Hz, JH‑F = 9.7 Hz, J = 1.7 Hz), 4.48
(dd, 1H, J = 10.5 Hz, J = 1.7 Hz), 6.83 (d, 1H, J = 7.6 Hz), 6.90 (s,
1H), 7.00 (d, 1H, J = 7.6 Hz), 7.09 (s, 2H), 7.14 (t, 1H, J = 7.6 Hz).
13C NMR (CDCl3, 100 MHz) δ, ppm: 19.3 (CH3), 20.0 (q, CH3, JC‑F
= 3.6 Hz), 21.6 (CH3), 35.4 (q, C
2, JC‑F = 1.9 Hz), 47.9 (q, C
1, JC‑F =
28.7 Hz), 48.6 (C3), 125.0, 126.9, 127.7 (q, CF3, JC‑F = 280.2 Hz),
128.1, 128.8, 129.9, 130.6, 133.2, 133.7, 136.5 (q, JC‑F = 2.0 Hz), 137.8,
144.0, 145.2. 19F NMR (CDCl3, 376 MHz) δ, ppm: −66.71 (d, CF3,
JH‑F = 9.7 Hz). MS (GC−MS, EI), m/z, (Irel., %): 304 (60) [M]+, 289
(100), 212 (20), 197 (15), 143 (10), 129 (10), 110 (5), 91 (5).




indane (cis-3d). Obtained in a mixture with indane trans-3d. Total
yield 36 mg, 42% (cis/trans ratio 1:3). Pale yellow oil. 1H NMR
(CDCl3, 400 MHz) δ, ppm: 2.23−2.26 (m, 1H), 2.29 (s, 3H, CH3),
2.35 (s, 3H, CH3), 2.38 (s, 3H, CH3), 2.93 (dt, 1H, J = 14.1 Hz, J =
10.0 Hz), 3.91 (pseudo-quintet, 1H, J = 9.2 Hz, JH‑F = 9.2 Hz), 4.36
(dd, 1H, J = 10.0 Hz, J = 5.2 Hz), 6.76 (s, 1H), 6.95 (s, 1H), 6.97−
7.01 (m, 2H), 7.06 (d, 1H, J = 8.0 Hz), 7.19−7.23 (m, 1H). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 20.4 (q, CH3, JC‑F = 4.0 Hz), 21.2 (CH3),
21.6 (CH3), 35.5 (q, C
2, JC‑F = 3.4 Hz), 47.7 (q, C
1, JC‑F = 29.0 Hz),
49.2 (C3), 124.3, 125.4, 127.3, 127.7 (q, CF3, JC‑F = 280.1 Hz), 128.4,
129.1, 130.6, 133.1, 135.8, 138.1, 138.9, 144.9, 148.0. 19F NMR
(CDCl3, 376 MHz) δ, ppm: −66.75 (d, CF3, JH‑F = 9.2 Hz). MS
(GC−MS, EI), m/z, (Irel., %): 304 (65) [M]+, 289 (100), 235 (8), 220
(7), 211 (7), 197 (10), 178 (5), 143 (8), 129 (10), 109 (6), 101 (5),




indane (trans-3d). Obtained in a mixture with indane cis-3d. 1H NMR
(CDCl3, 400 MHz) δ, ppm: 2.23 (s, 3H, CH3), 2.33−2.35 (m, 1H),
2.35 (s, 3H, CH3), 2.38 (s, 3H, CH3), 2.77 (dd, 1H, J = 13.7 Hz, J =
7.2 Hz), 3.91 (pseudo-quintet, 1H, J = 9.5 Hz, JH‑F = 9.5 Hz), 4.52 (dd,
1H, J = 10.2 Hz, J = 7.2 Hz), 6.56 (s, 1H), 6.91 (s, 1H), 6.98 (d, 1H, J
= 7.6 Hz), 7.01 (s, 1H), 7.09 (d, 1H, J = 7.6 Hz), 7.23 (t, 1H, J = 7.6
Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 19.5 (q, CH3, JC‑F = 2.7
Hz), 21.4 (CH3), 21.6 (CH3), 38.6 (q, C
2, JC‑F = 1.6 Hz), 46.8 (q, C
1,
JC‑F = 27.9 Hz), 50.3 (C
3), 123.6, 125.6, 127.7, 128.6 (q, CF3, JC‑F =
280.9 Hz), 128.6, 129.3, 129.7, 133.1, 136.4, 138.4, 139.0, 144.4, 149.4.
19F NMR (CDCl3, 376 MHz) δ, ppm: −68.88 (d, CF3, JH‑F = 9.5 Hz).
MS (GC−MS, EI), m/z, (Irel., %): 304 (65) [M]+, 289 (100), 235
(10), 220 (5), 211 (6), 197 (10), 178 (5), 143 (10), 129 (10), 109 (6),
101 (5), 89 (5), 77 (5). HRMS (ESI): C19H19F3Na found 327.1330
[M + Na]+; calcd. 327.1337.
rel-(1S,3S)-1-(Triﬂuoromethyl)-4,5,7-trimethyl-3-phenylindane
(cis-3e). Yield 68 mg, 76% (from pseudocumene), 22 mg, 24% (from
mesitylene). Colorless oil. 1H NMR (CDCl3, 400 MHz) δ, ppm: 1.91
(s, 3H, CH3), 2.28 (s, 3H, CH3), 2.32−2.36 (m, 1H), 2.36 (s, 3H,
CH3), 3.00 (dt, 1H, J = 14.1 Hz, J = 10.6 Hz), 3.85 (pseudo-quintet,
1H, J = 9.6 Hz, JH‑F = 9.6 Hz), 4.56 (d, 1H, J = 10.6 Hz), 7.02 (s, 1H),
7.07 (d, 2H, J = 7.4 Hz), 7.19 (m, 1H), 7.27 (m, 2H). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 16.2 (CH3), 19.7 (CH3), 19.8 (q, CH3,
JC‑F = 3.6 Hz), 35.7 (q, C
2, JC‑F = 1.7 Hz), 47.7 (q, C
1, JC‑F = 28.8 Hz),
48.8 (C3), 126.1, 127.7 (q, CF3, JC‑F = 280.1 Hz), 128.0, 128.2, 131.6,
131.7, 133.2, 134.1 (q, JC‑F = 1.9 Hz), 137.8, 144.5, 145.2.
19F NMR
(CDCl3, 376 MHz) δ, ppm: −66.93 (d, CF3, JH‑F = 9.6 Hz). MS
(GC−MS, EI), m/z, (Irel., %): 304 (62) [M]+, 289 (100), 235 (15),
115 (10), 91 (9). HRMS (ESI): C19H19F3Na found 327.1330 [M +
Na]+; calcd. 327.1337.
rel-(1S,3R)-1-(Triﬂuoromethyl)-4,5,7-trimethyl-3-phenylindane
(trans-3e). Yield 30 mg, 34%. Colorless solid, mp 96−98 °C (MeOH).
1H NMR (CDCl3, 400 MHz) δ, ppm: 1.64 (s, 3H, CH3), 2.11−2.19
(dt, 1H, J = 14.0 Hz, J = 9.3 Hz), 2.19 (s, 3H, CH3), 2.35 (s, 3H,
CH3), 2.82 (dd, 1H, J = 14.0 Hz, J = 7.7 Hz), 3.93 (pseudo-quintet,
1H, J = 9.3 Hz, JH‑F = 9.3 Hz), 4.60 (pseudo-t, 1H, J = 8.7 Hz), 6.95 (s,
1H), 7.07 (d, 2H, J = 7.2 Hz), 7.21 (t, 1H, J = 7.2 Hz), 7.28 (t, 2H, J =
7.2 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 16.2 (CH3), 19.3 (q,
CH3, JC‑F = 2.8 Hz), 19.9 (CH3), 39.2 (q, C
2, JC‑F = 1.9 Hz), 47.0 (q,
C1, JC‑F = 27.8 Hz), 50.6 (C
3), 126.4, 127.8, 128.5 (q, CF3, JC‑F = 280.8
Hz), 131.1 (C6), 131.2, 132.4, 133.9 (q, JC‑F = 1.7 Hz), 138.2, 146.2,
146.6. 19F NMR (CDCl3, 376 MHz) δ, ppm: −69.57 (d, CF3, JH‑F =
9.3 Hz). MS (GC−MS, EI), m/z, (Irel., %): 304 (51) [M]+, 289 (100),
235 (15), 211 (6), 183 (5), 157 (9), 115 (15), 91 (11), 77 (5). HRMS
(ESI): C19H19F3Na found 327.1330 [M + Na]
+; calcd. 327.1337.
rel-(1S,3S)-1-(Triﬂuoromethyl)-4,5,7-trimethyl-3-(3-methyl-
phenyl)indane (cis-3f). Yield 52 mg, 60%. Pale yellow oil. 1H NMR
(CDCl3, 400 MHz) δ, ppm: 1.90 (s, 3H, CH3), 2.28 (s, 3H, CH3),
2.30−2.35 (m, 1H), 2.31 (s, 3H, CH3), 2.35 (s, 3H, CH3), 2.98 (dt,
1H, J = 14.3 Hz, J = 10.5 Hz), 3.83 (pseudo-quintet, 1H, J = 9.7 Hz,
JH‑F = 9.7 Hz), 4.51 (d, 1H, J = 10.5 Hz), 6.82 (d, 1H, J = 7.6 Hz), 6.90
(s, 1H), 7.00 (d, 1H, J = 7.6 Hz), 7.01 (s, 1H), 7.23 (t, 1H, J = 7.6
Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 16.2 (CH3), 19.7 (CH3),
19.8 (q, CH3, JC‑F = 3.5 Hz), 21.6 (CH3), 35.7 (q, C
2, JC‑F = 1.9 Hz),
47.7 (q, C1, JC‑F = 28.8 Hz), 48.8 (C
3), 125.1, 126.8, 127.7 (q, CF3, JC‑F
= 280.3 Hz), 128.0, 128.8, 131.7, 131.7, 133.2, 134.1 (q, JC‑F = 2.0 Hz),
137.7, 137.8, 144.5, 145.4. 19F NMR (CDCl3, 376 MHz) δ, ppm:
−66.94 (d, CF3, JH‑F = 9.7 Hz). MS (GC−MS, EI), m/z, (Irel., %): 318
(55) [M]+, 303 (100), 249 (10), 226 (15), 211 (10), 197 (5), 157 (8),
129 (5), 105 (5). HRMS (ESI): C20H21F3Na found 341.1489 [M +
Na]+; calcd. 341.1493.
rel-(1S,3S)-1-(Triﬂuoromethyl)-4,5,7-trimethyl-3-(4-methyl-
phenyl)indane (cis-3g). Yield 66 mg, 50%. Colorless solid, mp 77−79
°C (MeOH). 1H NMR (CDCl3, 400 MHz) δ, ppm: 1.90 (s, 3H,
CH3), 2.27 (s, 3H, CH3), 2.32 (s, 3H, CH3), 2.27−2.32 (m, 1H), 2.34
(s, 3H, CH3), 2.97 (dt, 1H, J = 14.2 Hz, J = 10.4 Hz), 3.82 (pseudo-
quintet, 1H, J = 9.7 Hz, JH‑F = 9.7 Hz), 4.50 (d, 1H, J = 10.4 Hz), 6.94
(d, 2H, J = 7.9 Hz), 7.00 (s, 1H), 7.06 (d, 2H, J = 7.9 Hz). 13C NMR
(CDCl3, 100 MHz) δ, ppm: 16.2 (CH3), 19.7 (CH3), 19.8 (q, CH3,
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JC‑F = 3.6 Hz), 21.2 (CH3), 35.7 (q, C
2, JC‑F = 1.8 Hz), 47.7 (q, C
1, JC‑F
= 28.8 Hz), 48.4 (C3), 127.7 (q, CF3, JC‑F = 280.2 Hz), 127.9, 128.9,
131.6, 131.6, 133.2, 134.1 (q, JC‑F = 1.9 Hz), 135.5, 137.8, 141.5, 145.4.
19F NMR (CDCl3, 376 MHz) δ, ppm: −66.90 (d, CF3, JH‑F = 9.7 Hz).
MS (GCMS, EI), m/z, (Irel., %): 318 (50) [M]
+, 303 (100), 249 (8),
226 (25), 197 (5), 157 (8), 117 (5), 89 (5). HRMS (ESI): C20H21F3
found 341.1490 [M + Na]+; calcd. 341.1493.
rel-(1S,3R)-1-(Triﬂuoromethyl)-4,5,7-trimethyl-3-(4-methyl-
phenyl)indane (trans-3g). Yield 30 mg, 23%. Colorless solid, mp 95−
97 °C (MeOH). 1H NMR (CDCl3, 400 MHz) δ, ppm: 1.66 (s, 3H,
CH3), 2.13 (dt, 1H, J = 14.0 Hz, J = 9.3 Hz), 2.19 (s, 3H, CH3), 2.33
(s, 3H, CH3), 2.35 (s, 3H, CH3), 2.79 (dd, 1H, J = 14.0 Hz, J = 7.7
Hz), 3.92 (pseudo-quintet, 1H, J = 9.3 Hz, JH‑F = 9.3 Hz), 4.56
(pseudo-t, 1H, J = 8.7 Hz), 6.94 (s, 1H), 6.96 (d, 2H, J = 8.0 Hz), 7.09
(d, 2H, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 16.2
(CH3), 19.3 (q, CH3, JC‑F = 2.8 Hz), 19.9 (CH3), 21.2 (CH3), 39.3 (q,
C2, JC‑F = 1.7 Hz), 47.0 (q, C
1, JC‑F = 27.8 Hz), 50.2 (C
3), 127.7, 128.5
(q, CF3, JC‑F = 280.7 Hz), 129.5, 131.1, 131.3, 132.3, 134.0 (q, JC‑F =
1.7 Hz), 135.9, 138.1, 143.6, 146.3. 19F NMR (CDCl3, 376 MHz) δ,
ppm: −69.54 (d, CF3, JH‑F = 9.3 Hz). MS (GC−MS, EI), m/z, (Irel.,
%): 318 (55) [M]+, 303 (100), 249 (10), 226 (20), 211 (9), 197 (5),
157 (10), 142 (5), 129 (7), 117 (7), 105 (5), 91 (5). HRMS (ESI):
C20H21F3Na found 341.1488 [M + Na]
+; calcd. 341.1493.
rel-(1S,3S)-1-(Triﬂuoromethyl)-4,5,7-trimethyl-3-(4-chloro-
phenyl)indane (cis-3h). Yield 62 mg, 70% (from pseudocumene), 40
mg, 45% (from mesitylene). Pale yellow oil. 1H NMR (CDCl3, 400
MHz) δ, ppm: 1.90 (s, 3H, CH3), 2.28 (s, 3H, CH3), 2.28−2.31 (m,
1H), 2.34 (s, 3H, CH3), 2.98 (dt, 1H, J = 14.3 Hz, J = 10.4 Hz), 3.84
(pseudo-quintet, 1H, J = 9.7 Hz, JH‑F = 9.7 Hz), 4.52 (d, 1H, J = 10.4
Hz), 6.99 (d, 2H, J = 8.4 Hz), 7.02 (s, 1H), 7.23 (d, 2H, J = 8.4 Hz).
13C NMR (CDCl3, 100 MHz) δ, ppm: 16.2 (CH3), 19.7 (CH3), 19.8
(q, CH3, JC‑F = 3.4 Hz), 35.6 (q, C
2, JC‑F = 1.9 Hz), 47.6 (q, C
1, JC‑F =
28.8 Hz), 48.1 (C3), 127.6 (q, CF3, JC‑F = 280.2 Hz), 128.4, 129.4,
131.4, 131.8, 131.9, 133.4, 134.1 (q, JC‑F = 1.9 Hz), 138.0, 143.0, 144.7.
19F NMR (CDCl3, 376 MHz) δ, ppm: −66.98 (d, CF3, JH‑F = 9.7 Hz).
MS (GC−MS, EI), m/z, (Irel., %): 338/340 (67/20) [M]+, 323/325
(100/35), 303 (15), 269 (20), 254 (7), 226 (12), 143 (5), 101 (10).




phenyl)indane (trans-3h). Yield 32 mg, 36%. Pale yellow oil. 1H
NMR (CDCl3, 400 MHz) δ, ppm: 1.65 (s, 3H, CH3), 2.08 (dt, 1H, J =
14.0 Hz, J = 9.2 Hz), 2.19 (s, 3H, CH3), 2.34 (s, 3H, CH3), 2.80 (dd,
1H, J = 14.0 Hz, J = 7.7 Hz), 3.62 (pseudo-quintet, 1H, J = 9.2 Hz, JH‑F
= 9.2 Hz), 4.58 (pseudo-t, 1H, J = 8.6 Hz), 6.95 (s, 1H), 7.00 (d, 2H, J
= 8.4 Hz), 7.25 (d, 2H, J = 8.4 Hz). 13C NMR (CDCl3, 100 MHz) δ,
ppm: 16.3 (CH3), 19.3 (q, CH3, JC‑F = 2.6 Hz), 19.8 (CH3), 39.1 (q,
C2, JC‑F = 1.8 Hz), 47.0 (q, C
1, JC‑F = 28.0 Hz), 49.9 (C
3), 128.4 (q,
CF3, JC‑F = 280.7 Hz), 129.0, 129.1, 131.1, 131.3, 132.1, 132.5, 133.9
(q, JC‑F = 1.7 Hz), 138.3, 145.2, 145.7.
19F NMR (CDCl3, 376 MHz) δ,
ppm: −69.65 (d, CF3, JH‑F = 9.2 Hz). MS (GC−MS, EI), m/z, (Irel.,
%): 338/340 (69/23) [M]+, 323/325 (100/35), 303 (10), 269 (22),
254 (9), 226 (15), 143 (8), 101 (10). HRMS (ESI): C19H18ClF3Na
found 361.0943 [M + Na]+; calcd. 361.0947.
rel-(1S,3S)-1-(Triﬂuoromethyl)-4,5,7-trimethyl-3-(4-methoxy-
phenyl)indane (cis-3i). Yield 52 mg, 60%. Pale yellow oil. 1H NMR
(CDCl3, 400 MHz) δ, ppm: 1.90 (s, 3H, CH3), 2.27 (s, 3H, CH3),
2.27−2.31 (m, 1H), 2.34 (s, 3H, CH3), 2.95 (dt, 1H, J = 14.3 Hz, J =
10.4 Hz), 3.79 (s, 3H, CH3), 3.83 (pseudo-quintet, 1H, J = 9.8 Hz, JH‑F
= 9.8 Hz), 4.50 (d, 1H, J = 10.4 Hz), 6.80 (d, 2H, J = 8.6 Hz), 6.96 (d,
2H, J = 8.6 Hz), 7.00 (s, 1H). 13C NMR (CDCl3, 100 MHz) δ, ppm:
16.1 (CH3), 19.7 (CH3), 19.8 (q, CH3, JC‑F = 3.5 Hz), 35.8 (q, C
2, JC‑F
= 1.7 Hz), 47.7 (q, C1, JC‑F = 28.6 Hz), 48.0 (C
3), 55.3 (CH3), 113.6,
127.7 (q, CF3, JC‑F = 280.2 Hz), 129.0, 131.5, 131.6, 133.2, 134.0 (q,
JC‑F = 2.0 Hz), 136.7, 137.8, 145.6, 157.9.
19F NMR (CDCl3, 376
MHz) δ, ppm: −66.86 (d, CF3, JH‑F = 9.8 Hz). MS (GC−MS, EI), m/
z, (Irel., %): 334 (73) [M]
+, 319 (73), 303 (10), 250 (8), 226 (100),
211 (11), 157 (23), 142 (9), 125 (15), 89 (6). HRMS (ESI):
C20H21F3ONa found 357.1439 [M + Na]
+; calcd. 357.1442.
(E)-1,1,1-Triﬂuoro-2,4,4-tris(4-methoxyphenyl)butane (4a). Yield
24 mg, 21%. Pale yellow oil. 1H NMR (CDCl3, 400 MHz) δ, ppm:
2.43−2.50 (m, 1H), 2.66−2.73 (m, 1H), 3.00−3.10 (m, 1H), 3.57 (dd,
1H, J = 11.9 Hz, J = 3.9 Hz), 3.75 (s, 3H, CH3), 3.81 (s, 3H, CH3),
3.84 (s, 3H, CH3), 6.79 (d, 2H, J = 8.6 Hz), 6.86 (d, 2H, J = 8.6 Hz),
6.91 (d, 2H, J = 8.6 Hz), 7.04 (d, 2H, J = 8.4 Hz), 7.05 (d, 2H, J = 8.4
Hz), 7.12 (d, 2H, J = 8.6 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm:
34.9 (C3), 45.9 (C4), 47.3 (q, C2, JC‑F = 26.7 Hz), 55.4 (CH3), 114.0,
114.3, 114.3, 126.2 (q, JC‑F = 1.7 Hz), 127.3 (q, C
1, JC‑F = 279.2 Hz),
128.3, 129.1, 130.5, 134.8, 137.2, 158.1, 158.5, 159.6. 19F NMR
(CDCl3, 376 MHz) δ, ppm: −69.93 (d, CF3, JH‑F = 9.5 Hz). MS
(GC−MS, EI), m/z, (Irel., %): 430 (20) [M]+, 227 (100), 212 (6), 169




28 mg, 35%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ, ppm: 5.03−
5.04 (m, 1H), 5.62 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.2 Hz, J = 1.5 Hz),
6.81−6.82 (m, 1H), 6.84 (ddq, 1H, J = 15.6 Hz, J = 6.8 Hz, JH‑F = 2.0
Hz), 6.98 (dd, 1H, J = 5.1 Hz, J = 3.5 Hz), 7.23−7.25 (m, 3H), 7.29−
7.32 m (3H). 13C NMR (CDCl3, 100 MHz) δ, ppm: 48.2 (C
1′), 120.3
(q, C3′, JC‑F = 33.7 Hz), 123.2 (q, C4′, JC‑F = 269.7 Hz), 125.2, 125.9,
127.1, 127.7, 128.3, 129.0, 140.9, 141.8 (q, C2′, JC‑F = 6.3 Hz), 144.6.
19F NMR (CDCl3, 376 MHz) δ, ppm: −63.84 (dt, CF3, JH‑F = 6.2 Hz,
JH‑F = 2.0 Hz). MS (GC−MS, EI), m/z, (Irel., %): 268 (100) [M]+, 235
(13), 199 (36), 184 (30), 171 (22), 165 (33), 127 (16), 115 (89), 97
(26), 77 (15), 63 (10), 45 (32), 39 (16). HRMS (ESI): C14H11F3SAg
found 374.9591 [M + Ag]+; calcd. 374.9579.
(E)-2-(4,4,4-Triﬂuoro-1-(3-methylphenyl)but-2-en-1-yl)thiophene
(5b). Yield 18 mg, 23%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 2.35 (s, 3H, CH3), 4.97−4.99 (m, 1H), 5.61 (dqd, 1H, J = 15.6
Hz, JH‑F = 6.2 Hz, J = 1.5 Hz), 6.81 (m, 1H), 6.82 (ddq, 1H, J = 15.6
Hz, J = 6.9 Hz, JH‑F = 2.0 Hz), 6.97 (dd, 1H, J = 5.1 Hz, J = 3.5 Hz),
7.02−7.04 (m, 2H), 7.11 (d, 1H, J = 7.5 Hz), 7.23 (dd, 1H, J = 5.1 Hz,
J = 1.2 Hz), 7.25−7.27 (m, 1H). 13C NMR (CDCl3, 100 MHz) δ,
ppm: 21.6 (CH3), 48.2 (C
1′), 120.1 (q, C3′, JC‑F = 33.6 Hz), 123.2 (q,
C4′, JC‑F = 269.6 Hz), 125.1, 125.4, 125.8, 127.1, 128.5, 128.9, 129.0,
138.8, 140.8, 141.9 (q, C2′, JC‑F = 6.3 Hz), 144.8. 19F NMR (CDCl3,
376 MHz) δ, ppm: −63.81 (dt, CF3, JH‑F = 6.2 Hz, JH‑F = 2.0 Hz). MS
(GC−MS, EI), m/z, (Irel., %): 282 (100) [M]+, 267 (30), 249 (13),
213 (18), 198 (23), 183 (14), 165 (13), 129 (36), 121 (11), 97 (16),
65 (5), 45 (8). HRMS (ESI): C15H13F3SAg found 388.9744 [M +
Ag]+; calcd. 388.9741.
(E)-2-(4,4,4-Triﬂuoro-1-(4-methylphenyl)but-2-en-1-yl)thiophene
(5c). Yield 24 mg, 31%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 2.35 (s, 3H, CH3), 4.98−5.00 (m, 1H), 5.61 (dqd, 1H, J = 15.6
Hz, JH‑F = 6.2 Hz, J = 1.5 Hz), 6.81 (d, 1H, J = 3.5 Hz), 6.82 (ddq, 1H,
J = 15.6 Hz, J = 6.8 Hz, JH‑F = 2.0 Hz), 6.97 (dd, 1H, J = 5.1 Hz, J = 3.5
Hz), 7.12 (d, 2H, J = 8.1 Hz), 7.17 (d, 2H, J = 8.1 Hz), 7.23 (dd, 1H, J
= 5.1 Hz, J = 1.1 Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.2
(CH3), 47.9 (C
1′), 120.1 (q, C3′, JC‑F = 33.6 Hz), 123.2 (q, C4′, JC‑F =
269.7 Hz), 125.1, 125.7, 127.1, 128.2, 129.7, 137.4, 137.9, 142.0 (q,
C2′, JC‑F = 6.4 Hz), 145.0. 19F NMR (CDCl3, 376 MHz) δ, ppm:
−63.81 (dt, CF3, JH‑F = 6.2 Hz, JH‑F = 2.0 Hz). MS (GC−MS, EI), m/
z, (Irel., %): 282 (100) [M]
+, 267 (35), 249 (11), 213 (20), 198 (19),
183 (17), 165 (10), 129 (36), 115 (10), 97 (13), 45 (7). HRMS
(ESI): C15H13F3SAg found 388.9739 [M + Ag]
+; calcd. 388.9741.
(E)-2-(1-(4-Chlorophenyl)-4,4,4-Triﬂuorobut-2-en-1-yl)thiophene
(5d). Yield 32 mg, 41%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ,
ppm: 5.01−5.02 (m, 1H), 5.61 (dqd, 1H, J = 15.6 Hz, JH‑F = 6.2 Hz, J
= 1.6 Hz), 6.79 (ddq, 1H, J = 15.6 Hz, J = 6.8 Hz, JH‑F = 2.0 Hz), 6.81
(d, 1H, J = 3.5 Hz), 6.98 (dd, 1H, J = 5.1 Hz, J = 3.5 Hz), 7.17 (d, 2H,
J = 8.5 Hz), 7.25 (dd, 1H, J = 5.1 Hz, J = 1.6 Hz), 7.33 (d, 2H, J = 8.5
Hz). 13C NMR (CDCl3, 100 MHz) δ, ppm: 47.5 (C
1′), 120.7 (q, C3′,
JC‑F = 33.9 Hz), 123.1 (q, C
4′, JC‑F = 269.7 Hz), 125.4, 126.0, 127.2,
129.2, 129.7, 133.7, 139.3, 141.3 (q, C2′, JC‑F = 6.3 Hz), 143.9. 19F
NMR (CDCl3, 376 MHz) δ, ppm: −63.90 (dt, CF3, JH‑F = 6.2 Hz, JH‑F
= 2.0 Hz). MS (GC−MS, EI), m/z, (Irel., %): 302/304 (100/35) [M]+,
267 (74), 247 (6), 233 (39), 218 (10), 198 (18), 183 (46), 171 (27),
165 (15), 149 (32), 121 (12), 97 (25), 63 (7), 45 (20). HRMS (ESI):
C14H10ClF3SAg found 408.9200 [M + Ag]
+; calcd. 408.9189.
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2,5-Bis((E)-4,4,4-triﬂuoro-1-phenylbut-2-en-1-yl)thiophene (6a).
Yield 14 mg, 10%. Yellow oil. 1H NMR (CDCl3, 400 MHz) δ, ppm:
4.92−4.93 (m, 2H), 5.55−5.64 (m, 2H), 6.65 (d, 2H, J = 1.5 Hz),
6.73−6.81 (m, 2H), 7.20−7.22 (m, 4H), 7.29−7.37 (m, 6H). 13C
NMR (CDCl3, 100 MHz) δ, ppm: 48.4 (C
1′), 120.3 (q, C3′, JC‑F =
33.7 Hz), 123.1 (q, C4′, JC‑F = 269.7 Hz), 125.7, 125.7, 127.8, 128.3,
129.1, 140.5, 141.5 (q, C2′, JC‑F 6.3 Hz), 144.3. 19F NMR (CDCl3, 376
MHz) δ, ppm: −63.846 (m, CF3), −63.850 (m, CF3). MS (GC−MS,
EI), m/z, (Irel., %): 452 (78) [M]
+, 357 (9), 267 (100), 183 (82), 165
(40), 133 (10), 115 (36), 91 (25), 77 (12), 45 (13). HRMS (ESI):
C24H18F6SAg found 559.0101 [M + Ag]
+; calcd. 559.0079.
2,5-Bis((E)-4,4,4-triﬂuoro-1-(3-methylphenyl)but-2-en-1-yl)thio-
phene (6b). Yield 12 mg, 18%. Yellow oil. 1H NMR (CDCl3, 400
MHz) δ, ppm: 2.34 (s, 6H, 2CH3), 4.87−4.88 (m, 2H), 5.55−5.64 (m,
2H), 6.64 (d, 2H, J = 0.9 Hz), 6.73−6.81 (m, 2H), 7.00−7.04 (m,
4H), 7.11 (d, 2H, J = 7.3 Hz), 7.22−7.25 (m, 2H). 13C NMR (CDCl3,
100 MHz) δ, ppm: 21.6 (CH3), 48.4 (C
1′), 120.1 (q, C3′, JC‑F = 33.7
Hz), 123.2 (q, C4′, JC‑F = 269.7 Hz), 125.3, 125.5, 125.6, 128.5, 128.9,
129.0, 138.8, 140.5, 141.6 (q, C2′, JC‑F = 6.4 Hz), 144.4. 19F NMR
(CDCl3, 376 MHz) δ, ppm: −63.808 (m, CF3), −63.813 (m, CF3).
MS (GC−MS, EI), m/z, (Irel., %): 408 (82) [M]+, 465 (10), 385 (8),
281 (100), 248 (7), 197 (48), 179 (12), 164 (11), 129 (11), 105 (9),




phene (6c). Yield 28 mg, 42%. Yellow oil. 1H NMR (CDCl3, 400
MHz) δ, ppm: 2.34 (s, 6H, CH3), 4.87−4.88 (m, 2H), 5.54−5.62 (m,
2H), 6.63 (d, 2H, J = 1.4 Hz), 6.72−6.79 (m, 2H), 7.08−7.10 (m,
4H), 7.14−7.16 (m, 4H). 13C NMR (CDCl3, 100 MHz) δ, ppm: 21.2
(CH3), 48.1 (C
1′), 120.1 (q, C3′, JC‑F = 33.7 Hz), 125.5 (q, C4′, JC‑F =
269.7 Hz), 125.4, 125.5, 128.2, 129.7, 137.5, 137.6, 141.7 (q, C2′, JC‑F
= 6.3 Hz), 144.5. 19F NMR (CDCl3, 376 MHz) δ, ppm: −63.80 (m,
CF3), −63.82 (m, CF3). MS (GC−MS, EI), m/z, (Irel., %): 480 (65)
[M]+, 465 (14), 411 (10), 385 (8), 281 (100), 248 (8), 197 (43), 179
(15), 164 (12), 129 (16), 105 (11), 91 (5). HRMS (ESI):
C26H22F6SAg found 587.0408 [M + Ag]
+; calcd. 587.0397.
2,5-Bis((E)-1-(4-chlorophenyl)-4,4,4-triﬂuorobut-2-en-1-yl)thio-
phene (6d). Yield 12 mg, 18%. Yellow oil. 1H NMR (CDCl3, 400
MHz) δ, ppm: 4.90−4.92 (m, 2H), 5.59 (dqd, 2H, J = 15.6 Hz, JH‑F =
6.3 Hz, J = 1.1 Hz), 6.65 (d, 2H, J = 2.1 Hz), 6.74 (ddq, 2H, J = 15.6
Hz, J = 6.9 Hz, JH‑F = 2.0 Hz), 7.13−7.15 (m, 4H), 7.31−7.34 (m,
4H). 13C NMR (CDCl3, 100 MHz) δ, ppm: 47.7 (C
1′), 120.8 (q, C3′,
JC‑F = 33.9 Hz), 123.0 (q, C
4′, JC‑F = 269.8 Hz), 125.8, 125.9, 129.3,
129.6, 133.8, 138.9, 140.8 (q, C2′, JC‑F = 6.3 Hz), 144.0. 19F NMR
(CDCl3, 376 MHz) δ, ppm: −63.926 (m, CF3), −63.928 (m, CF3).
MS (GC -MS, EI), m/z, (Irel., %): 520/522/524 (44/31/7) [M]
+, 485/
487 (12/4), 301/303 (100/38), 266 (8), 217 (31), 183 (9), 164 (22),
149 (9), 115 (10), 45 (6). HRMS (ESI): C24H16Cl2F6SAg found
626.9312 [M + Ag]+; calcd. 626.9299.
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(2) See reviews: (a) Wang, J.; Sańchez-Rosello,́ M.; Aceña, J. L.; del
Poza, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H.
Chem. Rev. 2014, 114, 2432−2506. (b) Ojima, I. J. Org. Chem. 2013,
78, 6358−6383. (c) Berger, R.; Resnati, G.; Metrangolo, P.; Weber, E.;
Hulliger, J. Chem. Soc. Rev. 2011, 40, 3496−3508. (d) Hunter, L.
Beilstein J. Org. Chem. 2010, 6, 38. (e) Ananikov, V. P.; Khemchyan, L.
L.; Ivanova, Yu. V.; Bukhtiyarov, V. I.; Sorokin, A. M.; Prosvirin, I. P.;
Vatsadze, S. Z.; Medved'ko, A. V.; Nuriev, V. N.; Dilman, A. D.; Levin,
V. V.; Koptyug, I. V.; Kovtunov, K. V.; Zhivonitko, V. V.; Likholobov,
V. A.; Romanenko, A. V.; Simonov, P. A.; Nenajdenko, V. G.;
Shmatova, O. I.; Muzalevskiy, V. M.; Nechaev, M. S.; Asachenko, A. F.;
Morozov, O. S.; Dzhevakov, P. B.; Osipov, S. N.; Vorobyeva, D. V.;
Topchiy, M. A.; Zotova, M. A.; Ponomarenko, S. A.; Borshchev, O. V.;
Luponosov, Yu. N.; Rempel, A. A.; Valeeva, A. A.; Stakheev, A. Yu.;
Turova, O. V.; Mashkovsky, I. S.; Sysolyatin, S. V.; Malykhin, V. V.;
Bukhtiyarova, G. A.; Terent'ev, A. O.; Krylov, I. B. Russ. Chem. Rev.
2014, 83, 885.
(3) Shimizu, M.; Takeda, Y.; Higashi, M.; Hiyama, T. Angew. Chem.,
Int. Ed. 2009, 48, 3653−3656.
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